One-pot diagnostic methods based on CRISPR/Cas and Argonaute nucleases: strategies and perspectives.
Trends Biotechnol
; 2024 Jul 20.
Article
em En
| MEDLINE
| ID: mdl-39034177
ABSTRACT
CRISPR/Cas and Argonaute (Ago) proteins, which target specific nucleic acid sequences, can be applied as diagnostic tools. Despite high specificity and efficiency, achieving sensitive detection often necessitates a preamplification step that involves opening the lid and multistep operation, which may elevate the risk of contamination and prove inadequate for point-of-care testing. Hence, various one-pot detection strategies have been developed that enable preamplification and sensing in a single operation. We outline the challenges of one-pot detection with Cas and Ago proteins, present several main implementation strategies, and discuss future prospects. This review offers comprehensive insights into this vital field and explores potential improvements to detection methods that will be beneficial for human health.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Trends Biotechnol
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
China